| Citation: | MU Hong, CAO Pengyu, ZHOU Shan, GUO Tong, CHEN Siyu, Jalalimanesh Rahim, CHEN Yuru, SUN Yulin, LIU Jiexin, XU Bin, MA Li. The effect of syncope on the overall survival after surgery for hepatocellular carcinoma patients[J]. Chinese Journal of General Practice, 2026, 24(2): 205-208. doi: 10.16766/j.cnki.issn.1674-4152.004361 |
| [1] |
BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
| [2] |
XIE J, LIN X, FAN X, et al. Global burden and trends of primary liver cancer attributable to comorbid type 2 diabetes mellitus among people living with hepatitis B: an observational trend study from 1990 to 2019[J]. J Epidemiol Glob Health, 2024, 14(2): 398-410. doi: 10.1007/s44197-024-00237-1
|
| [3] |
DU J S, HSU S H, WANG S N. The current and prospective adjuvant therapies for hepatocellular carcinoma[J]. Cancers(Basel), 2024, 6(7): 1422. DOI: 10.3390/cancers16071422.
|
| [4] |
LORENZEN M O B, FARKAS D K, ADELBORG K, et al. Syncope as a sign of occult cancers: a population-based cohort study[J]. Br J Cancer, 2020, 122(4): 595-600. doi: 10.1038/s41416-019-0692-2
|
| [5] |
XIE D Y, ZHU K, REN Z G, et al. A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights[J]. Hepatobiliary Surg Nutr, 2023, 12(2): 216-228. doi: 10.21037/hbsn-22-469
|
| [6] |
中华心血管病杂志编辑委员会, 中国生物医学工程学会心律分会, 中国老年学和老年医学学会心血管病专业委员会, 等. 晕厥诊断与治疗中国专家共识(2018)[J]. 中华心血管病杂志, 2019, 47(2): 96-107.
Editorial Board of Chinese Journal of Cardiology, Heart Rhythm Branch of Chinese Society of Biomedical Engineering, Cardiovascular Diseases Branch of China Association of Gerontology and Geriatrics, et al. Chinese expert consensus statement on clinical diagnosis and treatment of syncope 2018[J]. Chin J Cardiol, 2019, 47(2): 96-107.
|
| [7] |
AKSU T, BRIGNOLE M, CALO L, et al. Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: a scientific statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS) and the Latin American Heart Rhythm Society (LAHRS)[J]. Europace, 2024, 26(8): euae206. DOI: 10.1093/europace/euae206.
|
| [8] |
HAN B, ZHENG R, ZENG H, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1): 47-53.
|
| [9] |
DUCREUX M, ABOU-ALFA G K, BEKAⅡ-SAAB T, et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022[J]. ESMO Open, 2023, 8(3): 101567. DOI: 10.1016/j.esmoop.2023.101567.
|
| [10] |
MA Y N, JIANG X, SONG P, et al. Neoadjuvant therapies in resectable hepatocellular carcinoma: exploring strategies to improve prognosis[J]. Biosci Trends, 2024, 18(1): 21-41. doi: 10.5582/bst.2023.01436
|
| [11] |
ZHENG Y, ZHU M, LI M. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2020, 146(10): 2439-2446. doi: 10.1007/s00432-020-03331-6
|
| [12] |
LI Y C, LI L Y, TONG H C, et al. Pulmonary artery intimal sarcoma mimicking pulmonary thromboembolism: a case report[J]. Medicine(Baltimore), 2021, 100(6): e24699. DOI: 10.1097/MD.0000000000024699.
|
| [13] |
MAGNON C, HONDERMARCK H. The neural addiction of cancer[J]. Nat Rev Cancer, 2023, 23(5): 317-334. doi: 10.1038/s41568-023-00556-8
|
| [14] |
AMATO M, PIAZZA P, FERRARI I, et al. Rare perinephric myxoid pseudotumor of fat causing ureteropelvic junction obstruction: a case report[J]. CEN Case Rep, 2023, 12(2): 210-214.
|
| [15] |
KHORANA A A, MACKMAN N, FALANGA A, et al. Cancer-associated venous thromboembolism[J]. Nat Rev Dis Primers, 2022, 8(1): 11. DOI: 10.1038/s41572-022-00336-y.
|
| [16] |
YEO Y H, LEE Y T, TSENG H R, et al. Alpha-fetoprotein: past, present, and future[J]. Hepatol Commun, 2024, 8(5): e0422. DOI: 10.1097/HC9.0000000000000422.
|
| [17] |
LIU D, SONG T. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China[J]. Biosci Trends, 2021, 15(3): 142-147. doi: 10.5582/bst.2021.01083
|
| [18] |
COURI T, PILLAI A. Goals and targets for personalized therapy for HCC[J]. Hepatol Int, 2019, 13(2): 125-137. doi: 10.1007/s12072-018-9919-1
|
| [19] |
GALLI E, PATELLI G, VILLA F, et al. Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: a systematic review[J]. Cancer Treat Rev, 2025, 135: 102908. DOI: 10.1016/j.ctrv.2025.102908.
|
| [20] |
DOMINGUEZ D A, WONG P, MELSTROM L G. Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review[J]. Hepatobiliary Surg Nutr, 2024, 13(1): 39-55. doi: 10.21037/hbsn-22-526
|
| [21] |
CHANG Y, WONG C E, LEE P H, et al. Survival outcome of surgical resection vs. radiotherapy in brain metastasis from colorectal cancer: a meta-analysis[J]. Front Med(Lausanne), 2022, 9: 768896. DOI: 10.3389/fmed.2022.768896.
|
| [22] |
伍龙, 吴欢, 黄飞, 等. 循环肿瘤DNA在结直肠癌中的应用[J]. 中华全科医学, 2024, 22(3): 368-371. doi: 10.16766/j.cnki.issn.1674-4152.003404
WU L, WU H, HUANG F, et al. Circulating tumor DNA in colorectal cancer[J]. Chinese Journal of General Practice, 2024, 22(3): 368-371. doi: 10.16766/j.cnki.issn.1674-4152.003404
|
| [23] |
HO N T, ABE S K, RAHMAN M S, et al. Diabetes is associated with increased liver cancer incidence and mortality in adults: a report from Asia Cohort Consortium[J]. Int J Cancer, 2024, 155(5): 854-870. doi: 10.1002/ijc.34965
|
| [24] |
SINGH M K, DAS B K, CHOUDHARY S, et al. Diabetes and hepatocellular carcinoma: a pathophysiological link and pharmacological management[J]. Biomed Pharmacother, 2018, 106: 991-1002. doi: 10.1016/j.biopha.2018.06.095
|
| [25] |
胡慧英, 张征宇. 运动干预在老年糖尿病周围神经病变患者中的应用效果[J]. 中华全科医学, 2020, 18(5): 769-772. doi: 10.16766/j.cnki.issn.1674-4152.001352
HU H Y, ZHANG Z Y. Effect of exercise intervention in elderly patients with diabetic peripheral neuropathy[J]. Chinese Journal of General Practice, 2020, 18(5): 769-772. doi: 10.16766/j.cnki.issn.1674-4152.001352
|
| [26] |
SUDO S Z, MONTAGNOLI T L, ROCHA B S, et al. Diabetes-induced cardiac autonomic neuropathy: impact on heart function and prognosis[J]. Biomedicines, 2022, 10(12): 3258. DOI: 10.3390/biomedicines10123258.
|
| [27] |
DAS B K, GADAD P C. Impact of diabetes on the increased risk of hepatic cancer: an updated review of biological aspects[J]. Diabetes Epidemiol Manag, 2021, 4: 100025. DOI: 10.1016/j.deman.2021.100025.
|